Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors HAUPPAUGE, N.Y., Dec. 17, 2020 — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors. “We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his p...
Source: globalbankingandfinance.com